Als Invest 1 B.v. - Net Worth and Insider Trading
Als Invest 1 B.v. Net Worth
The estimated net worth of Als Invest 1 B.v. is at least $17 Million dollars as of 2024-09-20. Als Invest 1 B.v. is the 10% Owner of Amylyx Pharmaceuticals Inc and owns about 5,895,280 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $17 Million. Details can be seen in Als Invest 1 B.v.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Als Invest 1 B.v. has not made any transactions after 2022-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Als Invest 1 B.v.
Als Invest 1 B.v. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Als Invest 1 B.v. owns 1 companies in total, including Amylyx Pharmaceuticals Inc (AMLX) .
Click here to see the complete history of Als Invest 1 B.v.’s form 4 insider trades.
Insider Ownership Summary of Als Invest 1 B.v.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AMLX | Amylyx Pharmaceuticals Inc | 2022-07-06 | 10 percent owner |
Als Invest 1 B.v. Latest Holdings Summary
Als Invest 1 B.v. currently owns a total of 1 stock. Als Invest 1 B.v. owns 5,895,280 shares of Amylyx Pharmaceuticals Inc (AMLX) as of July 6, 2022, with a value of $17 Million.
Latest Holdings of Als Invest 1 B.v.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AMLX | Amylyx Pharmaceuticals Inc | 2022-07-06 | 5,895,280 | 2.88 | 16,978,406 |
Holding Weightings of Als Invest 1 B.v.
Als Invest 1 B.v. Form 4 Trading Tracker
According to the SEC Form 4 filings, Als Invest 1 B.v. has made a total of 1 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the sale of 60,609 shares on July 6, 2022, which brought Als Invest 1 B.v. around $1 Million.
Insider Trading History of Als Invest 1 B.v.
- 1
Als Invest 1 B.v. Trading Performance
Als Invest 1 B.v. Ownership Network
Als Invest 1 B.v. Owned Company Details
What does Amylyx Pharmaceuticals Inc do?
Who are the key executives at Amylyx Pharmaceuticals Inc?
Als Invest 1 B.v. is the 10 percent owner of Amylyx Pharmaceuticals Inc. Other key executives at Amylyx Pharmaceuticals Inc include Chief Financial Officer James M Frates , Chief Legal Officer Gina Mazzariello , and director & Co-Chief Executive Officer Joshua B Cohen .
Amylyx Pharmaceuticals Inc (AMLX) Insider Trades Summary
Over the past 18 months, Als Invest 1 B.v. made no insider transaction in Amylyx Pharmaceuticals Inc (AMLX). Other recent insider transactions involving Amylyx Pharmaceuticals Inc (AMLX) include a net sale of 20,997 shares made by Gina Mazzariello , a net purchase of 2,992 shares made by James M Frates , and a net sale of 253,460 shares made by Morningside Venture Investments Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Amylyx Pharmaceuticals Inc (AMLX) in total and bought 190,000 shares, with a net purchase of 190,000 shares. During the past 18 months, 395,773 shares of Amylyx Pharmaceuticals Inc (AMLX) were sold and 199,000 shares were bought by its insiders, resulting in a net sale of 196,773 shares.
Amylyx Pharmaceuticals Inc (AMLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amylyx Pharmaceuticals Inc Insider Transactions
Als Invest 1 B.v. Mailing Address
Above is the net worth, insider trading, and ownership report for Als Invest 1 B.v.. You might contact Als Invest 1 B.v. via mailing address: Eerste Weleringdwarsstraal 54e, 1017 Tp, Amsterdam P7 1017.